Facial Serum and Mask and Ready-to-drink Jelly From Thai Rice
Development and Effectiveness Evaluation of Facial Serum and Mask and Ready-to-drink Jelly From Thai Rice (Oryza Sativa L.)
1 other identifier
interventional
104
1 country
1
Brief Summary
This study consisted of three sub-studies including 1) development and evaluation of facial serum from Thai rice on skin moisture, elasticity, oiliness, and melanin in healthy participants 2) development and evaluation of facial mask from Thai rice on skin moisture, elasticity, oiliness, and melanin in healthy participants and 3) development and evaluation of ready-to-drink jelly from Thai rice on controlling blood glucose and endurance time in healthy participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2024
CompletedFirst Posted
Study publicly available on registry
June 26, 2024
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFebruary 10, 2025
February 1, 2025
3 months
June 20, 2024
February 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Level of skin moisture
Studies 1 and 2 determine level of skin moisture in arbitrary unit (no unit) using Multiprobe Adapter System with Corneometer® CM 825 probe.
Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]
Level of skin elasticity
Studies 1 and 2 determine level of skin elasticity in arbitrary unit (no unit) using Multiprobe Adapter System with Cutometer® 580 probe.
Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]
Level of skin oiliness
Studies 1 and 2 determine level of skin oiliness in arbitrary unit (no unit) using Multiprobe Adapter System with Sebumeter® SM 815 probe.
Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]
Level of skin melanin
Studies 1 and 2 determine level of skin melanin in arbitrary unit (no unit) using Multiprobe Adapter System with Mexameter® MX18 probe.
Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]
Level of blood glucose
Study 3.1 determines level of blood glucose in mg/dL unit
Before jelly consumption and after jelly consumption at 30, 60, 90, and 120 minutes
Level of maximal oxygen consumption
Study 3.2 determines level of maximal oxygen consumption in mL/kg/min unit by walking or running on treadmill at intensity of 80% maximal heart rate.
After jelly consumption for 30 minutes
Concentration of interferon-gamma
Study 3.2 determines concentration of interferon-gamma in serum in pg (picogram)/mL unit
Before and immediately after maximal oxygen consumption test
Concentration of tumor necrosis factor-alpha
Study 3.2 determines concentration of tumor necrosis factor-alpha in serum in pg (picogram)/mL unit
Before and immediately after maximal oxygen consumption test
Concentration of interleukin-10
Study 3.2 determines concentration of interleukin-10 in serum in pg (picogram)/mL unit
Before and immediately after maximal oxygen consumption test
Level of superoxide dismutase activity
Study 3.2 determines level of superoxide dismutase activity in percentage (%) unit
Before and immediately after maximal oxygen consumption test
Concentration of malondialdehyde
Study 3.2 determines concentration of malondialdehyde in micromolar (uM) unit
Before and immediately after maximal oxygen consumption test
Study Arms (6)
Study 1: Facial serum with alpha albutin
ACTIVE COMPARATORParticipants will be randomly applied with home-based program of facial serum producing from 2% alpha albutin (standard facial serum) on either right side or left side of their face daily for 12 weeks.
Study 1: Facial serum with Tubtim Chumpae rice extract
EXPERIMENTALParticipants will be randomly applied with home-based program of facial serum producing from Tubtim Chumpae rice extract on either right side or left side of their face daily for 12 weeks.
Study 2: Facial mask with Hom Pathum rice extract
EXPERIMENTALParticipants will receive home-based program of facial mask with Hom Pathum rice extract for 30 min/day, 2 days/week for 12 weeks.
Study 3: Control jelly
ACTIVE COMPARATORParticipants will consume with control jelly at 3.5 g/kg body weight. Consumption will be taken at Burapha University.
Study 3: Jelly with Tubtim Chumpae rice
EXPERIMENTALParticipants will consume with Tubtim Chumpae rice jelly at 3.5 g/kg body weight. Consumption will be taken at Burapha University.
Study 3: Jelly with Hom Pathum rice
EXPERIMENTALParticipants will consume with Hom Pathum rice jelly at 3.5 g/kg body weight. Consumption will be taken at Burapha University.
Interventions
Applying with facial serum with 2% alpha albutin as active comparator daily for 12 weeks.
Applying with facial serum with Tubtim Chumpae rice extract as experimental intervention daily for 12 weeks.
Applying with facial mask with Hom Pathum rice extract as experimental intervention for 30 min/day, 2 days/week for 12 weeks.
Consumption with control jelly as active comparator at 3.5 g/kg body weight.
Consumption with jelly with Tubtim Chumpae rice as experimental intervention at 3.5 g/kg body weight.
Consumption with jelly with Hom Pathum rice as experimental intervention at 3.5 g/kg body weight.
Eligibility Criteria
You may qualify if:
- Male or female
- Age between 18 to 50 years
- Healthy
- Interested in facial serum with Thai rice extract or facial mask with Thai rice extract or jelly from with Thai rice
You may not qualify if:
- History of adverse effects from facial serum or mask application or jelly consumption
- Skin allergy
- Skin disorders
- Skin wounds
- History of allergy to Thai rice, particularly in Tubtim Chumpae and Hom Pathum
- History of allergy to facial serum or mask, i.e., serum or mask from rice
- History of allergy to gelatin
- Signs or symptoms of fever or infection
- Abnormal body mass index
- Regular smokers or alcohol drinkers (\>2 times per week)
- Regular exerciser (\>2 times per week or \>150 min per week)
- Regular intake of dietary supplements, i.e., vitamins, antioxidants
- Hypertension, diabetes, cardiovascular disease, respiratory disease, endocrine disease, neuromuscular disease, musculoskeletal disease, liver disease, renal disease, immune disease, infectious disease, or cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Piyapong Prasertsri
Mueang, Changwat Chon Buri, 20131, Thailand
Study Officials
- PRINCIPAL INVESTIGATOR
Piyapong Prasertsri, Ph.D.
Burapha University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor Dr.
Study Record Dates
First Submitted
June 20, 2024
First Posted
June 26, 2024
Study Start
September 1, 2024
Primary Completion
November 30, 2024
Study Completion
December 31, 2024
Last Updated
February 10, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make individual participant data available to other researchers.